Chartwell Investment Partners LLC Has $6.12 Million Stake in Integer Holdings Co. (NYSE:ITGR)

Chartwell Investment Partners LLC lessened its stake in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 10.1% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 47,033 shares of the medical equipment provider's stock after selling 5,287 shares during the quarter. Chartwell Investment Partners LLC owned about 0.14% of Integer worth $6,115,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of ITGR. State of New Jersey Common Pension Fund D increased its stake in shares of Integer by 1.8% during the third quarter. State of New Jersey Common Pension Fund D now owns 15,582 shares of the medical equipment provider's stock valued at $2,026,000 after buying an additional 268 shares during the period. Crossmark Global Holdings Inc. grew its holdings in Integer by 14.7% in the third quarter. Crossmark Global Holdings Inc. now owns 2,899 shares of the medical equipment provider's stock worth $377,000 after purchasing an additional 372 shares during the period. Legacy Capital Wealth Partners LLC raised its stake in Integer by 92.1% during the third quarter. Legacy Capital Wealth Partners LLC now owns 3,688 shares of the medical equipment provider's stock valued at $479,000 after buying an additional 1,768 shares during the last quarter. Portside Wealth Group LLC bought a new position in Integer in the 3rd quarter worth about $356,000. Finally, Moloney Securities Asset Management LLC grew its holdings in shares of Integer by 8.0% during the third quarter. Moloney Securities Asset Management LLC now owns 8,523 shares of the medical equipment provider's stock valued at $1,108,000 after buying an additional 632 shares during the last quarter. 99.29% of the stock is owned by institutional investors.

Integer Stock Down 1.9 %

Shares of NYSE ITGR traded down $2.60 during midday trading on Tuesday, reaching $136.89. 200,162 shares of the company's stock were exchanged, compared to its average volume of 311,135. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.09 and a current ratio of 3.28. Integer Holdings Co. has a 52-week low of $84.75 and a 52-week high of $140.91. The business's fifty day moving average price is $128.63 and its two-hundred day moving average price is $122.07. The stock has a market capitalization of $4.59 billion, a PE ratio of 43.09, a price-to-earnings-growth ratio of 1.96 and a beta of 1.09.

Integer (NYSE:ITGR - Get Free Report) last released its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, beating the consensus estimate of $1.36 by $0.07. The business had revenue of $431.42 million during the quarter, compared to analyst estimates of $440.59 million. Integer had a net margin of 6.70% and a return on equity of 11.63%. The business's quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the business earned $1.27 earnings per share. Analysts forecast that Integer Holdings Co. will post 5.33 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on ITGR shares. Bank of America boosted their target price on shares of Integer from $135.00 to $145.00 and gave the company a "buy" rating in a research note on Tuesday, October 1st. Citigroup lifted their target price on Integer from $124.00 to $130.00 and gave the company a "neutral" rating in a research note on Tuesday, October 1st. Oppenheimer started coverage on shares of Integer in a research note on Tuesday, July 16th. They issued an "outperform" rating and a $135.00 price target on the stock. Benchmark boosted their price target on shares of Integer from $130.00 to $140.00 and gave the stock a "buy" rating in a research report on Monday, October 21st. Finally, Piper Sandler reissued an "overweight" rating and set a $140.00 price objective (up from $125.00) on shares of Integer in a research note on Friday, October 25th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat, Integer currently has a consensus rating of "Moderate Buy" and an average price target of $139.75.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.